Keywords: Merck & Co, A:LK Abello, Ragweed allergy immunotherapy, USA, FDA, Milestone payment

Merck & Co submits ragweed AIT BLA to the FDA

Article | 11 March 2013

Print This

US pharma giant Merck & Co (NYSE: MRK) has submitted a Biologics License Application (BLA) to the US Food and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in